Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
Recruiting
Observational Study
Atrial Fibrillation
Ventricular Tachycardia
Premature Ventricular Contraction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Vanderbilt University Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to determine if electrophysiologic mapping and cardiac MRI can help identify patients that have genetic forms of cardiomyopathy that are at high risk for development of dangerous ventricular arrhythmias.
The investigators aim to study:
1. the prevalence and mechanism of inducible ventricular tachycardia
2. pace-mapping to define the site of origin of ventr…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 and older
* Diagnosed with AF, frequent PVCs, or VT before age 60
* Scheduled for catheter-based AF ablation (de-novo or repeat) OR catheter-based PVC ablation OR catheter-based VT ablation
* Able to provide written, informed consent
* P/LP variant in TTN or oth…
Contacts